10x基因组学 TXG
$59.28 +$1.22 (+2.10%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $61.20 +3.24%
开盘$57.89
昨收$58.06
当日区间$55.50 – $61.99
成交量4.52M
市值$7.72B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$151.04M-12.6% YoY
营业利润-$22.96M-117.1% YoY
净利润-$17.93M-151.9% YoY
摊薄每股收益-$0.14-150.5% YoY
自由现金流$15.39M-4.6% YoY
经营现金流$16.97M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率70.0%
营业利润率-14.9%
净利率-12.2%
净资产收益率-9.4%
资产收益率-7.5%
投入资本回报率-10.0%
流动比率5.69
负债/资产比率19.9%
现金及投资$552.03M
总负债$66.78M
净现金（净负债）$485.25M
自由现金流/营收19.7%
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $151.04M | $150.84M | $642.82M | $166.03M | $149.00M |
| 营业总收入 | $151.04M | $150.84M | $642.82M | $166.03M | $149.00M |
| 营业成本 | $38.54M | $44.67M | $198.94M | $52.99M | $48.70M |
| 毛利润 | $112.50M | $106.18M | $443.88M | $113.05M | $100.31M |
| 营业费用 | $135.45M | $123.22M | $554.77M | $132.59M | $132.55M |
| 销售及管理费用 | $78.66M | $66.38M | $316.13M | $76.62M | $75.36M |
| 研发费用 | $56.79M | $56.85M | $238.63M | $55.97M | $57.19M |
| 营业利润 | -$22.96M | -$17.05M | -$110.89M | -$19.54M | -$32.24M |
| 非经营性利息净收入（支出） | $4.80M | $5.01M | $20.05M | $6.89M | $5.20M |
| 非经营性利息收入 | $4.80M | $5.01M | $20.05M | $6.89M | $5.20M |
| 非经营性利息支出 | $0.00 | – | $0.00 | – | – |
| 其他收入（支出） | -$487,000.00 | -$815,000.00 | $50.93M | -$2.54M | -$1.17M |
| 特殊收益（费用） | $3.40M | $0.00 | $49.90M | $0.00 | $0.00 |
| -减：其他特殊支出 | -$3.40M | – | -$49.90M | $0.00 | – |
| 其他非经营性收入（支出） | -$3.89M | -$815,000.00 | $1.03M | -$2.54M | -$1.17M |
| 税前利润 | -$18.65M | -$12.85M | -$39.91M | -$15.19M | -$28.21M |
| 税费 | -$714,000.00 | $623,000.00 | $3.64M | $1.06M | -$733,000.00 |
| 净利润 | -$17.93M | -$13.47M | -$43.54M | -$16.25M | -$27.47M |
| 持续经营利润 | -$17.93M | -$13.47M | -$43.54M | -$16.25M | -$27.47M |
| 归属母公司净利润 | -$17.93M | -$13.47M | -$43.54M | -$16.25M | -$27.47M |
| 归属普通股股东净利润 | -$17.93M | -$13.47M | -$43.54M | -$16.25M | -$27.47M |
| 基本每股收益 | -$0.14 | -$0.10 | -$0.35 | -$0.13 | -$0.22 |
| 摊薄每股收益 | -$0.14 | -$0.10 | -$0.35 | -$0.13 | -$0.22 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $1.03B | $1.02B | $1.04B | $1.04B | $1.03B |
| 流动资产合计 | $674.67M | $669.73M | $684.45M | $684.45M | $659.83M |
| 现金及现金等价物与短期投资 | $552.03M | $539.85M | $523.41M | $523.41M | $482.08M |
| -现金及现金等价物 | $502.51M | $490.29M | $473.97M | $473.97M | $432.51M |
| -短期投资 | $49.52M | $49.56M | $49.44M | $49.44M | $49.58M |
| 应收款 | $50.63M | $56.14M | $82.49M | $82.49M | $96.59M |
| -应收账款 | $47.55M | $39.03M | $47.01M | $47.01M | $43.78M |
| -其他应收款 | $3.08M | $17.11M | $35.48M | $35.48M | $52.81M |
| 存货 | $52.62M | $53.49M | $56.34M | $56.34M | $61.96M |
| 其他流动资产 | $19.39M | $20.26M | $22.21M | $22.21M | $19.20M |
| 非流动资产合计 | $355.40M | $346.03M | $356.91M | $356.91M | $367.53M |
| 固定资产净值 | $272.01M | $278.98M | $287.16M | $287.16M | $296.18M |
| -固定资产原值 | $439.77M | $439.93M | $440.63M | $440.63M | $441.99M |
| -累计折旧 | -$167.76M | -$160.95M | -$153.46M | -$153.46M | -$145.81M |
| 商誉及其他无形资产 | $68.08M | $64.42M | $66.84M | $66.84M | $69.27M |
| -商誉 | $6.92M | $4.51M | $4.51M | $4.51M | $4.51M |
| -其他无形资产 | $61.16M | $59.91M | $62.33M | $62.33M | $64.76M |
| 其他非流动资产 | $15.31M | $2.62M | $2.91M | $2.91M | $2.08M |
| 负债合计 | $204.52M | $201.44M | $245.04M | $245.04M | $242.24M |
| 流动负债合计 | $118.51M | $113.60M | $153.45M | $153.45M | $147.32M |
| 应付款 | $30.22M | $27.77M | $25.49M | $25.49M | $23.66M |
| -应付账款 | $20.69M | $17.43M | $12.73M | $12.73M | $18.07M |
| -应付税款合计 | $6.95M | $6.52M | $7.22M | $7.22M | $5.59M |
| -其他应付款 | $2.58M | $3.82M | $5.54M | $5.54M | – |
| 一年内应计费用 | $16.01M | $18.87M | $19.81M | $19.81M | $21.30M |
| 短期债务及融资租赁负债 | $12.02M | $11.33M | $10.99M | $10.99M | $10.54M |
| -一年内到期融资租赁负债 | $12.02M | $11.33M | $10.99M | $10.99M | $10.54M |
| 一年内递延负债 | $23.61M | $24.34M | $23.90M | $23.90M | $22.14M |
| 其他流动负债 | $18.07M | $19.44M | $41.06M | $41.06M | $42.80M |
| 非流动负债合计 | $86.01M | $87.84M | $91.59M | $91.59M | $94.92M |
| 长期债务及融资租赁负债 | $66.78M | $70.06M | $73.38M | $73.38M | $76.44M |
| -长期融资租赁负债 | $66.78M | $70.06M | $73.38M | $73.38M | $76.44M |
| 一年以上递延负债 | $9.68M | $10.14M | $10.50M | $10.50M | $10.87M |
| 其他非流动负债 | $9.55M | $7.64M | $7.71M | $7.71M | $7.60M |
| 股东权益合计 | $825.55M | $814.32M | $796.33M | $796.33M | $785.12M |
| 股东权益 | $825.55M | $814.32M | $796.33M | $796.33M | $785.12M |
| 股本 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| -普通股 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| -优先股 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 资本公积 | $2.37B | $2.34B | $2.31B | $2.31B | $2.28B |
| 留存收益 | -$1.54B | -$1.52B | -$1.51B | -$1.51B | -$1.49B |
| 不影响留存收益的损益 | $77,000.00 | $114,000.00 | $225,000.00 | $225,000.00 | $138,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $16.97M | $26.12M | $136.05M | $40.78M | $43.21M |
| 持续经营经营活动现金流净额 | $16.97M | $26.12M | $136.05M | $40.78M | $43.21M |
| 持续经营净利润 | -$17.93M | -$13.47M | -$43.54M | -$16.25M | -$27.47M |
| 折旧、折耗与摊销 | $11.68M | $11.91M | $43.82M | $12.10M | $12.25M |
| 其他非现金项目 | $3.10M | -$250,000.00 | -$346,000.00 | -$121,000.00 | $701,000.00 |
| 营运资金变动 | -$4.06M | $5.29M | $24.94M | $18.58M | $31.77M |
| -应收款变动 | $5.50M | $26.11M | $6.44M | $14.10M | $22.91M |
| -存货变动 | $3.00M | $2.70M | $27.95M | $5.58M | $7.29M |
| -预付资产变动 | $1.21M | $1.95M | -$2.34M | -$2.99M | $1.38M |
| -应付账款及应计费用变动 | -$268,000.00 | -$1.97M | -$7.28M | -$632,000.00 | -$7.24M |
| -其他流动资产变动 | -$12.21M | $282,000.00 | $689,000.00 | -$1.60M | -$149,000.00 |
| -其他流动负债变动 | -$2.83M | -$2.90M | -$8.91M | -$2.65M | -$2.32M |
| -其他营运资金变动 | $1.54M | -$20.88M | $8.39M | $6.76M | $9.91M |
| 投资活动现金流净额 | -$7.74M | -$1.31M | -$13.44M | -$1.81M | -$8.80M |
| 持续经营投资活动现金流净额 | -$7.74M | -$1.31M | -$13.44M | -$1.81M | -$8.80M |
| 固定资产购置及出售净额 | -$1.59M | -$1.60M | -$5.94M | -$1.78M | -$687,000.00 |
| 投资购置及出售净额 | $454,000.00 | $286,000.00 | $1.77M | $624,000.00 | $502,000.00 |
| 筹资活动现金流 | $3.02M | -$8.42M | $6.80M | $2.24M | $617,000.00 |
| 持续经营筹资活动现金流净额 | $3.02M | -$8.42M | $6.80M | $2.24M | $617,000.00 |
| 股票期权行使所得 | $3.02M | $273,000.00 | $6.80M | $2.24M | $617,000.00 |
| 其他筹资费用净额 | $0.00 | -$8.69M | – | – | – |
| 期末现金余额 | $502.51M | $490.29M | $473.97M | $473.97M | $432.71M |
| 现金净变动 | $12.26M | $16.39M | $129.42M | $41.21M | $35.03M |
| 期初现金余额 | $490.29M | $473.97M | $344.07M | $432.71M | $397.71M |
| 汇率变动影响 | -$28,000.00 | -$73,000.00 | $484,000.00 | $43,000.00 | -$33,000.00 |
| 自由现金流 | $15.39M | $24.52M | $130.12M | $39.00M | $42.53M |
| 无形资产购置及出售净额 | – | – | $0.00 | $0.00 | – |
| 其他投资变动净额 | – | – | -$9.27M | -$652,000.00 | – |
暂无评论——快来第一个聊聊 TXG。
登录后参与讨论。